PIGMENTARY DISORDER, RETICULATE, WITH SYSTEMIC MANIFESTATIONS
|
0.700 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Defective DNA Polymerase α-Primase Leads to X-Linked Intellectual Disability Associated with Severe Growth Retardation, Microcephaly, and Hypogonadism.
|
31006512 |
2019 |
PIGMENTARY DISORDER, RETICULATE, WITH SYSTEMIC MANIFESTATIONS
|
0.700 |
GermlineCausalMutation
|
disease |
ORPHANET |
DNA polymerase-α regulates the activation of type I interferons through cytosolic RNA:DNA synthesis.
|
27019227 |
2016 |
PIGMENTARY DISORDER, RETICULATE, WITH SYSTEMIC MANIFESTATIONS
|
0.700 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
DNA polymerase-α regulates the activation of type I interferons through cytosolic RNA:DNA synthesis.
|
27019227 |
2016 |
PIGMENTARY DISORDER, RETICULATE, WITH SYSTEMIC MANIFESTATIONS
|
0.700 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
A systematic, large-scale resequencing screen of X-chromosome coding exons in mental retardation.
|
19377476 |
2009 |
PIGMENTARY DISORDER, RETICULATE, WITH SYSTEMIC MANIFESTATIONS
|
0.700 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
PIGMENTARY DISORDER, RETICULATE, WITH SYSTEMIC MANIFESTATIONS
|
0.700 |
Biomarker
|
disease |
CTD_human |
|
|
|
PARTINGTON X-LINKED MENTAL RETARDATION SYNDROME
|
0.300 |
GermlineCausalMutation
|
disease |
ORPHANET |
DNA polymerase-α regulates the activation of type I interferons through cytosolic RNA:DNA synthesis.
|
27019227 |
2016 |
Autoinflammatory disorder
|
0.300 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
DNA polymerase-α regulates the activation of type I interferons through cytosolic RNA:DNA synthesis.
|
27019227 |
2016 |
Intellectual Disability
|
0.120 |
GeneticVariation
|
group |
BEFREE |
Here, by using various complementary approaches, including classical linkage analysis, targeted next-generation sequencing, and whole-exome sequencing, we describe distinct missense and splice-impacting mutations in POLA1 in five unrelated families presenting with an X-linked syndrome involving intellectual disability, proportionate short stature, microcephaly, and hypogonadism.
|
31006512 |
2019 |
Intellectual Disability
|
0.120 |
Biomarker
|
group |
BEFREE |
The amplification by PCR of 12 markers located between POLA and DXS704 using genomic DNA from 192 MR males led to the identification, in a 9 year old mentally retarded boy, of a microdeletion which extends from DXS1202 to DXS1065.
|
8817333 |
1996 |
Intellectual Disability
|
0.120 |
Biomarker
|
group |
HPO |
|
|
|
Amyloidosis
|
0.110 |
Biomarker
|
disease |
BEFREE |
We demonstrate that beta-amyloid (Aβ) plaque burden starts to be more severe around P180 (moderate disease stage) in female transgenics when compared to males and that aging aggravates this sex-specific difference.
|
29505099 |
2018 |
Amyloidosis
|
0.110 |
Biomarker
|
disease |
HPO |
|
|
|
X-linked intellectual disability Van Esch type
|
0.100 |
CausalMutation
|
phenotype |
CLINVAR |
Defective DNA Polymerase α-Primase Leads to X-Linked Intellectual Disability Associated with Severe Growth Retardation, Microcephaly, and Hypogonadism.
|
31006512 |
2019 |
Colitis
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Diarrhea
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Dwarfism
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Fetal Growth Retardation
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Atrial Septal Defects
|
0.100 |
Biomarker
|
group |
HPO |
|
|
|
Ventricular Septal Defects
|
0.100 |
Biomarker
|
group |
HPO |
|
|
|
Hemiplegia
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Hernia, Inguinal
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Hypohidrosis
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Microcephaly
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Scoliosis, unspecified
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|